Djaksigulova, Diana https://orcid.org/0000-0002-9320-9764
Kaad, Sif G.
Korecki, Andrea J. https://orcid.org/0000-0001-6532-0695
Lam, Siu Ling https://orcid.org/0009-0003-7583-0789
Lengyell, Tess C. https://orcid.org/0000-0001-6292-0724
Simpson, Elizabeth M. https://orcid.org/0000-0002-0654-4303
Funding for this research was provided by:
Foundation Fighting Blindness (GR015664)
Foundation Fighting Blindness (GR015664)
Foundation Fighting Blindness (GR015664)
Foundation Fighting Blindness (GR015664)
Foundation Fighting Blindness (GR015664)
Foundation Fighting Blindness (GR015664)
Article History
Received: 13 August 2025
Revised: 6 February 2026
Accepted: 24 February 2026
First Online: 9 March 2026
Competing interests
: The authors declare no competing interests.
: All mice were bred and maintained in the pathogen-free mouse core facility of the Center for Molecular Medicine and Therapeutics at The University of British Columbia. All procedures involving animal work were in accordance with the guidelines of the Canadian Council on Animal Care and UBC Animal Care Committee (Protocols A21-0140 and A21-0184).
: All the authors have read and approved the manuscript and consent to its publication.